TY  - JOUR
AU  - Michaelides, Stefanos
AU  - Hartmann, Viktoria
AU  - Nüssler, Volkmar
AU  - Zielinski, Christoph
AU  - von Bergwelt-Baildon, Michael
AU  - Kobold, Sebastian
TI  - 11th Immunotherapy of Cancer conference (ITOC): A meeting report.
JO  - Human vaccines & immunotherapeutics
VL  - 21
IS  - 1
SN  - 2164-5515
CY  - Austin, Tex.
PB  - Landes Bioscience
M1  - DKFZ-2025-01459
SP  - 2532967
PY  - 2025
AB  - The Immunotherapy of Cancer (ITOC) meeting is an international conference providing a platform for immuno-oncologists worldwide to present and discuss their research and newest findings. Being held in Munich annually, the 11th edition took place in April 2025 and saw broad discussions about new concepts in the field of immuno-oncology, mixed with exciting clinical results but also with a glimpse back into the past. This was mirrored by the lifetime achievement award, given to Robert D. Schreiber for his groundbreaking work on the immune surveillance of cancer. ITOC11 impressively showcase how far immuno-oncology has come in a conference extending from the discipline's very beginnings up to some of the most exciting new findings in the field of cancer immunology. The conference has demonstrated that tumor immunology is not only about cancer and immune cells, but extends far beyond.
KW  - Humans
KW  - Neoplasms: therapy
KW  - Neoplasms: immunology
KW  - Immunotherapy: methods
KW  - Congresses as Topic
KW  - Cancer Vaccines: immunology
KW  - CAR T cell therapy (Other)
KW  - ITOC (Other)
KW  - Immunotherapy of Cancer (Other)
KW  - antibody therapy (Other)
KW  - cellular therapy (Other)
KW  - combination therapy (Other)
KW  - tumor immunology (Other)
KW  - tumor vaccination (Other)
KW  - Cancer Vaccines (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:40679247
DO  - DOI:10.1080/21645515.2025.2532967
UR  - https://inrepo02.dkfz.de/record/303012
ER  -